Nasengel (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasengel, is an alpha‑adrenergic agonist presented as a nasal spray for topical nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.\n\nGNH India supplies Nasengel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride is an alpha‑adrenergic nasal decongestant that reduces swelling of the nasal mucosa.\n\n- Common cold nasal congestion: provides rapid relief of a blocked nose by shrinking swollen blood vessels.\n- Sinusitis‑associated congestion: helps open sinus passages and eases pressure.\n- Allergic rhinitis: diminishes nasal blockage caused by allergic inflammation.

Xylometazoline Hydrochloride may cause local or systemic adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Nasal irritation: mild burning or stinging sensation.\n- Sneezing: transient increase in sneezing episodes.\n- Dry nasal mucosa: dryness or crusting inside the nose.\n- Headache: mild headache.\n\nSerious or Rare Side Effects:\n- Rebound congestion: worsening nasal blockage after prolonged use.\n- Hypertension: elevated blood pressure in susceptible individuals.\n- Cardiac arrhythmia: irregular heartbeat, rare but reported.

Before using Nasengel, consider the following precautions to ensure safe and effective treatment.\n\n- Duration of use: limit to no more than three consecutive days to avoid rebound congestion.\n- Pre‑existing cardiovascular disease: use with caution if you have hypertension or heart disease.\n- Pregnancy and breastfeeding: consult a healthcare professional before use.\n- Children under a certain age: follow age‑specific recommendations; not for infants unless directed.\n- Concomitant monoamine oxidase inhibitors: avoid simultaneous use due to possible systemic effects.\n- Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with certain medicines; be aware of the following.\n\nMajor Interactions (Avoid):\n- MAO inhibitors: may increase risk of hypertensive episodes.\n- Systemic decongestants (e.g., pseudoephedrine): additive vasoconstrictive effect leading to high blood pressure.\n\nModerate Interactions (Monitor Closely):\n- Antihypertensive agents: may reduce effectiveness of blood pressure medication.\n- Beta‑blockers: possible enhanced cardiovascular effects.\n- Tricyclic antidepressants: monitor for increased blood pressure.